▼ SELL
10b5-1 Plan
$ Value
$24K
Shares
6,057
Price
$4
Filed
Jun 9
Insider
Name
Landry Benjamin
Title
General Counsel
CIK
0001975281
Roles
Officer
Transaction Details
Transaction Date
2025-06-05
Code
S
Table
Non-Derivative
Ownership
Direct
Equity Swap
No
Shares After
151,125
Footnotes
The sale reported on this Form 4 was made pursuant to a written trading plan adopted by the Reporting Person on March 1st, 2025 in accordance with Rule 10b5-1.
Filing Info
Landry Benjamin's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2026-03-02 | HCAT | F | $35K |
| 2026-02-26 | HCAT | F | $11K |
| 2026-02-25 | HCAT | A | $0 |
| 2026-02-25 | HCAT | A | $0 |
| 2025-12-05 | HCAT | ▼ | $72K |
| 2025-12-01 | HCAT | F | $42K |
| 2025-09-05 | HCAT | ▼ | $21K |
| 2025-09-02 | HCAT | F | $11K |
| 2025-06-05 | HCAT | ▼ | $24K |
| 2025-06-02 | HCAT | F | $12K |
Other Insiders at HCAT (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
|
Llewelyn Linda
Chief People Officer
|
— | — | 2026-03-02 |
| Gallagher Duncan | — | — | 2026-02-17 |
| Larson-Green Julie | — | — | 2026-03-01 |
|
Alger Jason
Chief Financial Officer
|
— | — | 2026-03-02 |
|
Landry Benjamin
General Counsel
|
— | — | 2026-03-02 |
|
Albert Benjamin
CEO
|
— | — | 2026-03-10 |